Predicting Response to Treatment to Prevent Breast Cancer Patients From Dying of Side Effects: Precision Health AI Publishes Ground Breaking Predictive Results for Treatment Outcomes and Real World Data Driven Analysis of Care Variation in Targeted and IO Treatment at ASCO AI Model Results for Prediction of the Occurrence of Chemotherapeutic Induced Neutropenia Exceed Current Prediction Accuracy Standards by >50%. Precision Health AI, a SymphonyAI company, to present findings and other accepted publications at ASCO Meeting.(PRWeb May 17, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15499156.htm
Precision Health AI develops and provides oncology-focused integrated information and data-driven decision-making tools for CROs, providers and payers.